Winning Against Prostate Cancer
For more than two decades, Hoag Family Cancer Institute has been the number
one provider for urologic malignancies in Orange County, including the
highest volume of prostate cancer patients. With a multidisciplinary approach
that includes prevention, early detection, the use of standard and promising
new therapies, participation in laboratory and clinical research, and
extensive complementary care, the team at Hoag Family Cancer Institute
provides prostate cancer patients with every diagnostic and therapeutic
Of the 1 in 6 American men who will develop prostate cancer in their lifetime,
approximately 5-10% are in Hereditary Prostate Cancer (HPC) families.
Having a first degree relative (father, brother or son) with prostate cancer
doubles a man’s risk (to a chance of 1 in 3) of developing prostate
cancer. Men with two or more first degree relatives with prostate cancer
likely have a prostate cancer risk greater than 1 in 3.
With one exception (see below), at this time, genetic testing is not available
on a commercial basis for hereditary prostate cancer; however, in families
with multiple cases of prostate cancer in close relatives, referral can
be made to institutions which are researching hereditary prostate cancer genes.
Prostate cancer is known to occur more frequently, at a younger age and
possibly more aggressively in male carriers of the hereditary breast/ovarian
cancer (BRCA1 and BRCA2) genes. If prostate cancer occurs in a family
where there is also early-onset breast cancer and/or ovarian cancer, then
genetic testing of the family may be indicated.